Skip to main content
EJNMMI Research
Fig. 6 | EJNMMI Research

Fig. 6

From: Targeted scVEGF/177Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy

Fig. 6

scVEGF/177Lu induces a decrease in CD206 immunostaining in primary orthotopic MDA231luc tumors. Images of CD206 immunostaining were captured with ×5 objective. Waterfall plots for CD206 prevalence in individual microscopic fields on immunostained cryosections for control and scVEGF/177Lu-treated MDA231luc tumor-bearing mice at day 1 (a) and day 15 (b) after treatment. For each group, cryosections were prepared from four tumors harvested from two mice

Back to article page